Stephen Willey
Stock Analyst at Stifel
(3.46)
# 895
Out of 4,947 analysts
136
Total ratings
41.24%
Success rate
7.03%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stephen Willey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintains: Buy | $121 → $145 | $127.80 | +13.46% | 7 | Aug 14, 2025 | |
| NKTX Nkarta | Maintains: Buy | $14 → $12 | $2.33 | +415.02% | 4 | Aug 14, 2025 | |
| ABCL AbCellera Biologics | Maintains: Buy | $8 → $7 | $4.59 | +52.51% | 6 | Aug 8, 2025 | |
| EXEL Exelixis | Maintains: Hold | $38 → $41 | $38.31 | +7.02% | 19 | Jul 29, 2025 | |
| CELC Celcuity | Reinstates: Buy | $30 | $51.79 | -42.07% | 1 | Jul 1, 2025 | |
| CBIO Crescent Biopharma | Initiates: Buy | $28 | $13.79 | +103.05% | 1 | Jun 25, 2025 | |
| INCY Incyte | Upgrades: Buy | $75 → $107 | $86.92 | +23.10% | 6 | Jun 16, 2025 | |
| MGNX MacroGenics | Maintains: Hold | $6 → $5 | $1.59 | +215.46% | 3 | May 14, 2025 | |
| BOLT Bolt Biotherapeutics | Maintains: Hold | $25 → $20 | $5.15 | +288.35% | 4 | May 13, 2025 | |
| NRIX Nurix Therapeutics | Maintains: Buy | $36 → $35 | $10.58 | +230.81% | 5 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $5 | $2.14 | +133.64% | 5 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $1.45 | +175.86% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $27 → $2.5 | $1.27 | +96.85% | 7 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $120 | $2.85 | +4,110.53% | 2 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $28 | $14.36 | +94.99% | 6 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $11.64 | +303.78% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $0.83 | +384.26% | 7 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $34 → $3 | $2.08 | +44.23% | 3 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $7 | $4.89 | +43.15% | 10 | Apr 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $1.43 | +179.72% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $62 | $38.23 | +62.18% | 5 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $2.97 | +203.03% | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $2.01 | +498.50% | 1 | Nov 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $228 → $288 | $1.86 | +15,383.87% | 4 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $21 | $1.91 | +999.48% | 2 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $10 → $4 | $1.24 | +222.58% | 7 | Jul 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $123 | $448.91 | -72.60% | 3 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $48 → $47 | $43.78 | +7.35% | 2 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $102 → $109 | $57.54 | +89.43% | 3 | Aug 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Terminates: Hold | n/a | $20.92 | - | 2 | Jun 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $23 | $7.62 | +201.84% | 5 | Feb 7, 2018 |
Insmed
Aug 14, 2025
Maintains: Buy
Price Target: $121 → $145
Current: $127.80
Upside: +13.46%
Nkarta
Aug 14, 2025
Maintains: Buy
Price Target: $14 → $12
Current: $2.33
Upside: +415.02%
AbCellera Biologics
Aug 8, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $4.59
Upside: +52.51%
Exelixis
Jul 29, 2025
Maintains: Hold
Price Target: $38 → $41
Current: $38.31
Upside: +7.02%
Celcuity
Jul 1, 2025
Reinstates: Buy
Price Target: $30
Current: $51.79
Upside: -42.07%
Crescent Biopharma
Jun 25, 2025
Initiates: Buy
Price Target: $28
Current: $13.79
Upside: +103.05%
Incyte
Jun 16, 2025
Upgrades: Buy
Price Target: $75 → $107
Current: $86.92
Upside: +23.10%
MacroGenics
May 14, 2025
Maintains: Hold
Price Target: $6 → $5
Current: $1.59
Upside: +215.46%
Bolt Biotherapeutics
May 13, 2025
Maintains: Hold
Price Target: $25 → $20
Current: $5.15
Upside: +288.35%
Nurix Therapeutics
Apr 9, 2025
Maintains: Buy
Price Target: $36 → $35
Current: $10.58
Upside: +230.81%
Mar 21, 2025
Maintains: Buy
Price Target: $12 → $5
Current: $2.14
Upside: +133.64%
Feb 27, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.45
Upside: +175.86%
Jan 10, 2025
Downgrades: Hold
Price Target: $27 → $2.5
Current: $1.27
Upside: +96.85%
Nov 14, 2024
Maintains: Buy
Price Target: $150 → $120
Current: $2.85
Upside: +4,110.53%
Oct 28, 2024
Maintains: Buy
Price Target: $21 → $28
Current: $14.36
Upside: +94.99%
Oct 8, 2024
Initiates: Buy
Price Target: $47
Current: $11.64
Upside: +303.78%
Aug 20, 2024
Maintains: Buy
Price Target: $8 → $4
Current: $0.83
Upside: +384.26%
Jul 9, 2024
Downgrades: Hold
Price Target: $34 → $3
Current: $2.08
Upside: +44.23%
Apr 12, 2024
Maintains: Hold
Price Target: $7
Current: $4.89
Upside: +43.15%
Dec 19, 2023
Maintains: Buy
Price Target: $3 → $4
Current: $1.43
Upside: +179.72%
Dec 18, 2023
Maintains: Buy
Price Target: $53 → $62
Current: $38.23
Upside: +62.18%
Jan 27, 2023
Initiates: Buy
Price Target: $9
Current: $2.97
Upside: +203.03%
Nov 28, 2022
Initiates: Buy
Price Target: $12
Current: $2.01
Upside: +498.50%
Jun 26, 2020
Downgrades: Hold
Price Target: $228 → $288
Current: $1.86
Upside: +15,383.87%
Mar 17, 2020
Maintains: Buy
Price Target: $22 → $21
Current: $1.91
Upside: +999.48%
Jul 29, 2019
Downgrades: Hold
Price Target: $10 → $4
Current: $1.24
Upside: +222.58%
Aug 13, 2018
Maintains: Buy
Price Target: $125 → $123
Current: $448.91
Upside: -72.60%
Aug 8, 2018
Maintains: Hold
Price Target: $48 → $47
Current: $43.78
Upside: +7.35%
Aug 3, 2018
Maintains: Buy
Price Target: $102 → $109
Current: $57.54
Upside: +89.43%
Jun 25, 2018
Terminates: Hold
Price Target: n/a
Current: $20.92
Upside: -
Feb 7, 2018
Maintains: Buy
Price Target: $20 → $23
Current: $7.62
Upside: +201.84%